Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company’s multiple sclerosis products.
Related Posts
FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage
The decision that will eventually bar compounding pharmacies from making unbranded versions of the injection.
Starbucks barista strike expands to more than 300 stores in 45 states
The strike will affect only about 3% of all locations. A barista workers union is aiming to raise worker pay and highlight alleged unfair labor […]
CDC says 75 people affected in E. coli outbreak linked to McDonald’s Quarter Pounders
It is the latest tally of people affected since the agency announced the outbreak on Tuesday, initially citing 49 cases and one death across 10 […]